› $150,000,000 verdict in personal injury case
Pregnant women who take certain types of antidepressants are at greater risk for preterm delivery or other birth complications, according to a study published in the American Journal of Obstetrics & Gynecology. The findings add more fuel to the argument that antidepressants not be prescribed to pregnant women and women of childbearing age unless absolutely necessary.
Washington, DC — The use of selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors for the treatment of depression during pregnancy should be individualized based on their respective risks and benefits, according to a new Committee Opinion issued by The American College of Obstetricians and Gynecologists’ (ACOG) Committee on Obstetric Practice. The Committee also advised that a particular SSRI medication known as paroxetine (Paxil®) be avoided, when possible, by pregnant women or women planning to become pregnant due to the potential risk of fetal heart defects, newborn persistent pulmonary hypertension, and other negative effects.
